US Broker Ratings

Becton, Dickinson and Company (BDX) Stock Analysis: Unveiling a 25.85% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to command attention from investors with its robust portfolio of medical instruments and supplies. The company, with..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 27.39% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a major player in the biotechnology industry, focusing on transformative medicines for serious diseases. With its solid presence in the healthcare sector, Vertex..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating 22.82% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might want to turn their attention to Koninklijke Philips N.V. (NYSE: PHG). This Dutch-based giant, with a market capitalization of $26.13 billion, is..

Medtronic plc (MDT) Stock Analysis: Exploring a 29.62% Potential Upside in the Healthcare Sector

Medtronic plc (NYSE: MDT), a giant in the healthcare industry, continues to be a focal point for investors seeking stability and growth in the medical devices sector. With a market..

Haleon plc (HLN) Stock Analysis: Exploring a 23% Upside Amidst Steady Healthcare Demand

Haleon plc (HLN), a formidable player in the healthcare sector, is catching the eyes of investors with its promising growth potential. As a specialist in consumer healthcare products, Haleon has..

Centene Corporation (CNC) Stock Analysis: A 3.95% Potential Upside Amidst Healthcare Growth

Centene Corporation (NYSE: CNC) is a prominent player in the healthcare plans sector, holding a significant presence in the United States market. With a market capitalization of $20.57 billion, the..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 28.6% Upside Potential in the Animal Health Sector

For investors eyeing opportunities within the healthcare sector, Zoetis Inc. (NYSE: ZTS) presents an intriguing proposition. With a market capitalization of $49.33 billion, Zoetis stands as a formidable player in..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential with a 106.10% Return on Equity

As one of the leading titans in the global healthcare sector, Amgen Inc. (NASDAQ: AMGN) has consistently demonstrated its prowess in developing and delivering innovative human therapeutics. With a market..

Gilead Sciences (GILD) Stock Analysis: Evaluating a 21.44% Potential Upside in the Biopharma Giant

Gilead Sciences, Inc. (NASDAQ: GILD) remains a heavyweight in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $161.85 billion, this biopharmaceutical giant continues..

UnitedHealth Group (UNH) Stock Analysis: Discover the 8.78% Potential Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, is garnering significant attention from investors, driven by its robust market position and promising analyst ratings. As a leading..

Merck & Co., Inc. (MRK) Stock Analysis: A 15.94% Potential Upside with Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK), a cornerstone in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic partnerships. With a market capitalization of $276.38..

Atrium Therapeutics, Inc. (RNA): Investor Outlook Highlights 73.49% Upside Potential

Atrium Therapeutics, Inc. (NASDAQ: RNA), a biopharmaceutical innovator specializing in RNA therapeutics for cardiomyopathies, is garnering attention for its promising pipeline and significant upside potential. With a market capitalization of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 55.60% Potential Upside

For investors keen on the healthcare sector, particularly the medical devices industry, iRhythm Holdings, Inc. (NASDAQ: IRTC) presents an intriguing investment opportunity. With a market capitalization of $4.05 billion, this..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the Future of RNA-Targeted Therapeutics with Promising Forward P/E

For investors keen on the biotechnology sector, Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a company worth watching due to its cutting-edge research in RNA-targeted therapeutics and gene therapies. Although navigating..

Nuvalent, Inc. (NUVL) Stock Analysis: Unveiling a 32% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising pipeline of cancer therapies and a striking analyst consensus that forecasts a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 26% Potential Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, TG Therapeutics, Inc. (NASDAQ: TGTX) offers an intriguing opportunity. This biopharmaceutical company, with its focus on innovative treatments for B-cell..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a Potential 42% Upside in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the precision oncology sector, is capturing investor attention with a potential upside of 42.06%, according to analyst ratings. As a company..

Rhythm Pharmaceuticals (RYTM): Analyst Consensus Suggests 55% Upside Potential for Investors

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of the biotechnology sector with a targeted focus on rare neuroendocrine diseases. With a market capitalization of $6.06 billion, this Boston-based..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 101% Potential Upside in Biotech Innovation

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is making waves with its innovative approach to radiopharmaceuticals. With a market cap of $3.64 billion, this Australia-based company..

Legend Biotech Corporation (LEGN): Analyst Consensus Reveals 170% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is a notable player in the biotechnology sector, positioning itself at the forefront of innovative cancer treatments. Headquartered in Somerset, New Jersey, this biopharmaceutical company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds